BioSpace News Archive

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration has accepted for review the supplemental Biologics License Application for Dupixent® to treat adults and adolescents aged 12 years and older with chronic spontaneous urticaria that is not adequately controlled with the current standard of care, H1 antihistamine treatment.

Novotech, the leading Asia Pacific centred biotech CRO will be at BIO Europe to meet with clinical-stage biotechs and to share the benefits of Novotech’s recently expanded operations in Europe.

Sensorion a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, is pleased to announce its participation in the 6th Annual Bioprocessing Summit Europe, held on 14-16 March, 2023, in Barcelona, Spain.

Captor Therapeutics S.A. announced its strategic objectives for the period 2023 to 2025 aimed at building a clinical stage, major international player in the rapidly growing TPD space.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the fourth quarter and full year ended December 31, 2022, and provides a corporate update.

BioNxt Solutions Inc. is pleased to report that it has signed a definitive technology transfer and patent assignment agreement to acquire certain technology and intellectual property assets and rights related to a novel solid oral drug dosage form coating and delivery technology.

Two studies presented at the 2023 American Academy of Orthopaedic Surgeons Annual Meeting found that patients who had shoulder arthroplasty could return to play golf or racket sports within six months to one year, experiencing significantly decreased pain as well maintained or improved performance.

Oxford BioTherapeutics Ltd. announces it has been honoured with two prestigious awards: the ‘Tech Company of the Year’ and the ‘Special Recognition Award’, at The Business Magazine’s fourth annual Thames Valley SME Growth 100 Awards.

Jeito Capital, the largest fully independent private equity firm dedicated to healthcare and biopharma in Europe, announced that it has co-led a EUR 104 million financing in Noema Pharma, a clinical-stage biopharma company targeting debilitating central nervous system disorders.

iZafe Group (STO:IZAFE-B.ST) iZafe Group (publ.) hereby announces that its wholly owned subsidiary Pilloxa AB is expanding its digital support for patients to Germany in collaboration with Chiesi´s local office.